跳至主要内容
临床试验/DRKS00009875
DRKS00009875招募中不适用

on Alcoholic Fatty Liver Disease (NAFLD) and Small Intestinal Bacterial Overgrowth (SIBO) - NAFLD and SIBO

Hepatogastroenterology Unit, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Medical School, Athens University0 个研究点目标入组 60 人开始时间: 2016年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Enrolled patients (Arm1) should have radiological and/or biochemical and/or histological evidence of fatty liver.
  • Healthy controls (Arm 2) consist of participants that undergo upper gastrointestinal endoscopy in terms of dyspepsia investigation and have no evidence of any liver disease.
  • Cirrhotic controls (Arm 3) consist of patients with cirrhosis of any etiology.

排除标准

  • 1. Age <18 years
  • 2. Ongoing alcohol overconsumption
  • 3. Recent use of antibiotics (within the last 3 months)
  • 4. Recent upper gastrointestinal bleeding
  • 5. Inability to provide informed consent
  • Additionally for the Patient Group:
  • 1. Absence of any other liver related disease (viral hepatitis, metabolic liver diseases, hepatocellular carcinoma)

研究者

发起方
Hepatogastroenterology Unit, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Medical School, Athens University

相似试验